ABUS vs CHRW

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 12, 2026

ABUS

47.1
AI Score
VS
CHRW Wins

CHRW

58.8
AI Score

Investment Advisor Scores

ABUS

47score
Recommendation
HOLD

CHRW

59score
Recommendation
STRONG BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric ABUS CHRW Winner
Forward P/E 10.2459 21.645 ABUS
PEG Ratio 0 1.8324 Tie
Revenue Growth -90.6% 19.3% CHRW
Earnings Growth 0.0% 23.8% CHRW
Tradestie Score 47.1/100 58.8/100 CHRW
Profit Margin 84.2% 3.7% ABUS
Beta 1.00 1.00 Tie
AI Recommendation HOLD STRONG BUY CHRW

Relative Price Performance (Last 90 Days)

ABUS 1M: +11.5% · 3M: +19.3% CHRW 1M: +4.1% · 3M: -20.1%

Current Technical Phase

ABUS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (5.6% over 20 days), RSI 60

RSI (14): 60.0 · Price: $5.12

CHRW

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 50.2 · Price: $152.78

Fundamentals Snapshot

Metric ABUS CHRW
Market Cap
Forward P/E -46.1 20.4
Trailing P/E 6.5 28.7
Revenue (TTM)
Revenue Growth -0.9% 0.2%
Gross Margin 0.9% 0.1%
Operating Margin -5.7% 0.1%
EPS 0.79 5.31
Dividend Yield 0.02%

Frequently Asked Questions

Based on our detailed analysis, CHRW is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.